Xu et al. showed that GSK3B, downregulated by miR-132-3p, enhances etoposide-induced cell apoptosis in breast cancer [49] and that upregulated SMAD3 promotes the expression of androgen receptor (AR), resulting in the development of CRPC [50]. This evidence concerns the gene SMAD3 and breast cancer.